A randomised placebo-controlled trial of weekly paclitaxel and saracatinib (AZD0530) in platinum-resistant ovarian, fallopian tube or primary peritoneal cancer.
McNeish, I Ledermann, J Webber, L James, L Kaye, S Hall, M Hall, G Clamp, Andrew R Earl, H Banerjee, S
McNeish, I
Ledermann, J
Webber, L
James, L
Kaye, S
Hall, M
Hall, G
Clamp, Andrew R
Earl, H
Banerjee, S
Citations
Altmetric:
Abstract
We investigated whether the Src inhibitor saracatinib (AZD0530) improved efficacy of weekly paclitaxel in platinum-resistant ovarian cancer.
Description
Date
2014-07-28
Publisher
Collections
Keywords
Type
Article
Citation
A randomised placebo-controlled trial of weekly paclitaxel and saracatinib (AZD0530) in platinum-resistant ovarian, fallopian tube or primary peritoneal cancer. 2014: Ann Oncol